Effect of Phosphate Phase Incorporation on 3D-Printed Hydrogel Scaffolds: Towards Customizable Bone Graft Materials
Trifan A., Liciu E., Nedelcu AS., Dragomir M., Cristea DD., Mateescu CȘ.
Laboratory Study, published in Gels (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Gels (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40868795
- PMCID
- PMC12385390
- DOI
- 10.3390/gels11080665
- Citations
- 2
Abstract (original English)
Bone defects remain a significant clinical challenge, creating a severe need for advanced biomaterials for tissue regeneration. This study addresses this issue by developing 3D-printed composite hydrogels containing alginate, gelatine, and resorbable calcium phosphates (monetite and brushite) for bone tissue engineering. The scaffolds were fabricated using extrusion-based 3D printing and evaluated for their morphology, porosity, mechanical strength, swelling, degradation, and in vitro mineralization, while their cytocompatibility was assessed using LIVE/DEAD cell viability assays. The key findings demonstrate that calcium phosphate incorporation enhanced the mechanical stability by 15-25% compared to the controls, and mineral deposition increased significantly in the composite scaffolds. The developed hydrogels are bioactive and represent promising, customizable scaffolds for bone regeneration. These results support their further investigation as viable alternatives to traditional bone grafts for clinical bone tissue engineering applications.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.